Mukherjee D - Search Results

1

"Pulmonary embolism response teams: changing the paradigm in the care for acute pulmonary embolism": reply.

Porres-Aguilar M, Rosovsky RP, Jiménez D, Mukherjee D, Rivera-Lebron BN, Kaatz S, Anaya-Ayala JE, Jerjes-Sánchez C. Porres-Aguilar M, et al. Among authors: mukherjee d. J Thromb Haemost. 2023 May;21(5):1390-1392. doi: 10.1016/j.jtha.2023.02.001. J Thromb Haemost. 2023. PMID: 37121622 Free article. No abstract available.

2

Impact of Hospital-based Multidisciplinary Anticoagulation Stewardship Programs.

Porres-Aguilar M, Ansell J, Mukherjee D, Cota-Rangel X, Martínez-Zubieta R, Carrillo-Esper R, Burnett AE. Porres-Aguilar M, et al. Among authors: mukherjee d. Arch Med Res. 2023 Jan;54(1):1-6. doi: 10.1016/j.arcmed.2022.11.016. Epub 2022 Dec 5. Arch Med Res. 2023. PMID: 36481128 Review.

3

After revascularization for PAD, rivaroxaban reduced vascular events with a small increase in major bleeding.

Mukherjee D. Mukherjee D. Ann Intern Med. 2020 Aug 18;173(4):JC22. doi: 10.7326/ACPJ202008180-022. Ann Intern Med. 2020. PMID: 32805167

4

Updates in the Pharmacotherapy of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction.

Segovia F, Garcia H, Alkhateeb H, Mukherjee D, Nickel N. Segovia F, et al. Among authors: mukherjee d. Cardiovasc Hematol Disord Drug Targets. 2023;23(4):215-225. doi: 10.2174/011871529X258234230921112507. Cardiovasc Hematol Disord Drug Targets. 2023. PMID: 37921162

5

In acute MI and anemia, restrictive vs. liberal transfusion did not differ for a composite of recurrent MI or death at 30 d.

Mukherjee D. Mukherjee D. Ann Intern Med. 2024 Mar;177(3):JC29. doi: 10.7326/J24-0010. Epub 2024 Mar 5. Ann Intern Med. 2024. PMID: 38437693

6

Association Between Blood Transfusion Treatment Strategy for Acute Coronary Syndromes and Clinical Outcomes: A Meta-analysis of Randomized Clinical Trials.

Savani M, Bikdeli B, Kalra A, Aggarwal V, Mukherjee D, Chatterjee S. Savani M, et al. Among authors: mukherjee d. Am J Ther. 2024 Jan-Feb 01;31(1):e84-e87. doi: 10.1097/MJT.0000000000001500. Epub 2022 Apr 4. Am J Ther. 2024. PMID: 38231585 No abstract available.

7

Influenza vaccination in mitigating vascular events and risk.

Mares AC, Mukherjee D. Mares AC, et al. Among authors: mukherjee d. Curr Opin Cardiol. 2023 Jul 1;38(4):327-330. doi: 10.1097/HCO.0000000000001018. Epub 2022 Dec 28. Curr Opin Cardiol. 2023. PMID: 36728725 Review.

8

In HF, with or without PAD, dapagliflozin reduced a composite of worsening HF or CV death and did not increase amputations.

Mukherjee D. Mukherjee D. Ann Intern Med. 2023 Sep;176(9):JC99. doi: 10.7326/J23-0066. Epub 2023 Sep 5. Ann Intern Med. 2023. PMID: 37665990

9

Device Thrombosis with Bioresorbable Scaffolds.

Mukherjee D. Mukherjee D. N Engl J Med. 2017 Jun 15;376(24):2388-2389. doi: 10.1056/NEJMe1703202. Epub 2017 Mar 29. N Engl J Med. 2017. PMID: 28402239 No abstract available.

10

Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction.

Paz PA, Mantilla BD, Argueta EE, Mukherjee D. Paz PA, et al. Among authors: mukherjee d. Ann Transl Med. 2021 Mar;9(6):523. doi: 10.21037/atm-20-4602. Ann Transl Med. 2021. PMID: 33850920 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,122 results

Search Page